9030418K01Rik Inhibitors
Fam217b inhibitors, as classified here, are a group of compounds that can indirectly influence the function of Fam217b by modulating various cellular pathways or processes. The chemicals included in this category do not target Fam217b directly but can have an impact on the protein's stability, expression, or associated signaling pathways.
The chemical inhibitors listed affect a range of cellular targets and pathways. Kinase inhibitors like staurosporine, LY294002, U0126, SB203580, SP600125, and PD98059 can modulate signal transduction cascades, potentially impacting proteins like Fam217b that are downstream of these pathways. Rapamycin and geldanamycin target key regulatory proteins involved in cell growth and protein stability, respectively, which could indirectly influence Fam217b's role if it is associated with these cellular functions. Brefeldin A can interfere with protein trafficking, which could affect Fam217b if its function is related to intracellular transport. Wortmannin, similar to LY294002, can disrupt PI3K-related signaling and thus affect Fam217b activity. Cycloheximide and 2-deoxyglucose target protein synthesis and metabolism, respectively, potentially altering the cellular environment in a way that impacts Fam217b activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can broadly inhibit protein kinases, potentially affecting phosphorylation states and signaling pathways involving Fam217b. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter the PI3K/Akt pathway, potentially affecting downstream proteins including Fam217b if it is part of this signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK, which is part of the MAPK/ERK pathway; could modulate the pathway and indirectly influence the function or regulation of Fam217b. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect cell growth and proliferation pathways, potentially influencing Fam217b if it is involved in these processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can alter stress response pathways, potentially impacting Fam217b function if it is associated with these pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which is involved in the stress-activated MAPK pathway; could affect Fam217b function if it is linked to this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which could interfere with the MAPK/ERK signaling and indirectly influence Fam217b-associated processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of protein transport from the endoplasmic reticulum to the Golgi apparatus, which could affect Fam217b if it is involved in protein trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor like LY294002, wortmannin can disrupt the PI3K/Akt pathway and potentially impact Fam217b function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An Hsp90 inhibitor that could destabilize client proteins and potentially impact the stability or function of Fam217b if it is a client protein of Hsp90. | ||||||